rs28372783

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_004360.5(CDH1):​c.-197A>C variant causes a upstream gene change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0117 in 574,956 control chromosomes in the GnomAD database, including 305 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.011 ( 89 hom., cov: 33)
Exomes 𝑓: 0.012 ( 216 hom. )

Consequence

CDH1
NM_004360.5 upstream_gene

Scores

2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -1.06

Publications

9 publications found
Variant links:
Genes affected
CDH1 (HGNC:1748): (cadherin 1) This gene encodes a classical cadherin of the cadherin superfamily. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate the mature glycoprotein. This calcium-dependent cell-cell adhesion protein is comprised of five extracellular cadherin repeats, a transmembrane region and a highly conserved cytoplasmic tail. Mutations in this gene are correlated with gastric, breast, colorectal, thyroid and ovarian cancer. Loss of function of this gene is thought to contribute to cancer progression by increasing proliferation, invasion, and/or metastasis. The ectodomain of this protein mediates bacterial adhesion to mammalian cells and the cytoplasmic domain is required for internalization. This gene is present in a gene cluster with other members of the cadherin family on chromosome 16. [provided by RefSeq, Nov 2015]
CDH1 Gene-Disease associations (from GenCC):
  • blepharocheilodontic syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Illumina, Labcorp Genetics (formerly Invitae), G2P
  • CDH1-related diffuse gastric and lobular breast cancer syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P
  • hereditary breast carcinoma
    Inheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics
  • hereditary diffuse gastric adenocarcinoma
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet
  • cleft soft palate
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • orofacial cleft 3
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • blepharocheilodontic syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial ovarian cancer
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.54).
BP6
Variant 16-68737219-A-C is Benign according to our data. Variant chr16-68737219-A-C is described in ClinVar as Likely_benign. ClinVar VariationId is 676637.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.123 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CDH1NM_004360.5 linkc.-197A>C upstream_gene_variant ENST00000261769.10 NP_004351.1
CDH1NM_001317184.2 linkc.-197A>C upstream_gene_variant NP_001304113.1
CDH1NM_001317185.2 linkc.-1812A>C upstream_gene_variant NP_001304114.1
CDH1NM_001317186.2 linkc.-2016A>C upstream_gene_variant NP_001304115.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CDH1ENST00000261769.10 linkc.-197A>C upstream_gene_variant 1 NM_004360.5 ENSP00000261769.4
CDH1ENST00000422392.6 linkc.-197A>C upstream_gene_variant 1 ENSP00000414946.2
CDH1ENST00000566612.5 linkn.-197A>C upstream_gene_variant 1 ENSP00000454782.1
CDH1ENST00000566510.5 linkn.-197A>C upstream_gene_variant 5 ENSP00000458139.1

Frequencies

GnomAD3 genomes
AF:
0.0109
AC:
1657
AN:
151802
Hom.:
90
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00293
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0461
Gnomad ASJ
AF:
0.00260
Gnomad EAS
AF:
0.131
Gnomad SAS
AF:
0.00833
Gnomad FIN
AF:
0.00265
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000707
Gnomad OTH
AF:
0.0148
GnomAD4 exome
AF:
0.0120
AC:
5063
AN:
423036
Hom.:
216
Cov.:
4
AF XY:
0.0111
AC XY:
2480
AN XY:
222822
show subpopulations
African (AFR)
AF:
0.00227
AC:
20
AN:
8804
American (AMR)
AF:
0.0708
AC:
1156
AN:
16326
Ashkenazi Jewish (ASJ)
AF:
0.00450
AC:
57
AN:
12664
East Asian (EAS)
AF:
0.110
AC:
3016
AN:
27352
South Asian (SAS)
AF:
0.00652
AC:
278
AN:
42656
European-Finnish (FIN)
AF:
0.00256
AC:
75
AN:
29328
Middle Eastern (MID)
AF:
0.00265
AC:
5
AN:
1888
European-Non Finnish (NFE)
AF:
0.000683
AC:
177
AN:
259166
Other (OTH)
AF:
0.0112
AC:
279
AN:
24852
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
246
492
738
984
1230
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
40
80
120
160
200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0109
AC:
1657
AN:
151920
Hom.:
89
Cov.:
33
AF XY:
0.0118
AC XY:
878
AN XY:
74266
show subpopulations
African (AFR)
AF:
0.00292
AC:
121
AN:
41428
American (AMR)
AF:
0.0464
AC:
708
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.00260
AC:
9
AN:
3464
East Asian (EAS)
AF:
0.131
AC:
672
AN:
5142
South Asian (SAS)
AF:
0.00834
AC:
40
AN:
4798
European-Finnish (FIN)
AF:
0.00265
AC:
28
AN:
10568
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.000707
AC:
48
AN:
67930
Other (OTH)
AF:
0.0147
AC:
31
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.511
Heterozygous variant carriers
0
76
153
229
306
382
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00139
Hom.:
0
Bravo
AF:
0.0166
Asia WGS
AF:
0.0680
AC:
236
AN:
3476

ClinVar

Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 17, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.54
CADD
Benign
8.3
DANN
Benign
0.79
PhyloP100
-1.1
PromoterAI
0.30
Neutral

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs28372783; hg19: chr16-68771122; API